Adagio Medical Announces First Patient Treated In IDE Study Of Next-Generation vCLAS Ultra Ventricular Ablation System For Sustained Monomorphic Ventricular Tachycardia
Share
Why It Matters
Adagio Medical started testing a new heart rhythm device on patients. This is an early step to see if the device works safely and well.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.